Clinical Trial: A Phase I dose-escalation clinical trial to evaluate the safety, tolerability and pharmacokinetic profile of single and multiple doses of BXOS116 for injection in healthy participants (China)

China, Oct. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase I dose-escalation clinical trial to evaluate the safety, tolerability and pharmacokinetic profile of single and multiple doses of BXOS116 for injection in healthy participants'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133705

Registration Time: 2026/09/30

Type: Interventional study

Primary Sponsor: The Second Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330548

Published by HT Digital Content Services with permission from Health Daily Digest....